A review of the pharmacoeconomic research on Gemcitabine (GemzarTM) in the treatment of advanced non-small cell lung cancer
Year: 1997
Type: conference-abstract
Source: European Journal of Cancer
Authors: ME Minshall, AM Liepa
Institution: Eli Lilly (United States)
Language: English
Subfield: Economics and Econometrics
Domain: Social Sciences
Open Access status: closed
OpenAlex ID: W2017013305
